Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 6, 2007, Pages 573-578

  Yukawa, E ^a   Mori, S ^b   Ueda, K ^c   Nakada, Y ^c  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b Kumamoto Saishunsou National Hospital   (Japan)

^c SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Methotrexate; NONMEM; Population pharmacokinetics; Rheumatoid arthritics

Indexed keywords

METHOTREXATE; METOLATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HUMAN; JAPAN; LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; MALE; OUTCOME ASSESSMENT; PATIENT CARE; RHEUMATOID ARTHRITIS; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; METHOTREXATE; MODELS, BIOLOGICAL;

EID: 36249026181     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00859.x     Document Type: Article

References (14)

1. Tugwell P, Bennett K, Gent M (1987) Methotrexate in rheumatoid arthritis. Annals of Internal Medicine, 107, 358 366.
2. Frust DE (1985) Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. Journal of Rheumatology, 12 (Suppl. 12 11 14.
3. Weinblatt ME, Coblyn JS, Fox DA et al. (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. New England Journal of Medicine, 312, 812 822.
4. Anderson PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL (1985) Weekly pulse methotrevate in rheumatoid arthritis: clinical and immunologic effects in a randomized double-blind study. Annals of Internal Medicine, 103, 489 498.
5. Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS (1984) A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. Journal of Rheumatology, 11, 760 763.
6. Weinstein GD, Frost P (1971) Methotrexate for proriasis: a new therapeutic schedule. Archives of Dermatology, 103, 33 38.
7. Gaylis NB, Lechner B, Blechman WJ (1985) Clinical experience in the treatment of rheumatoid arthritis with oral or intramuscular low dose pulse methotrexate [abstract]. Proceedings the Sixteenth International Congress of Rheumatology, Sydney, Australia, 130, 213.
8. Beal SL, Sheiner LB (eds 1992) NONMEM user's guides. San Francisco : NONMEM Project Group, University of California at San Francisco.
9. Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics, 9, 503 512.
10. Bannwarth B, Pehourcq F, Schaeverbeke T, Dehais J (1996) Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clinical Pharmacokinetics, 30, 194 210.
11. Godfrey C, Sweeney K, Miller K, Hamilton R, Kremer J (1996) The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis. British Journal of Clinical Pharmacology, 46, 369 376.
12. Sinnett MJ, Groff GD, Raddatz DA, Franck WA, Bertino JS (1989) Methotrexate pharmacokinetics in patients with rheumatoid arthritis. Journal of Rheumatology, 16, 745 748.
13. Combe B, Edno L, Lafforgue P et al. (1995) Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients. British Journal of Rheumatology, 34, 421 428.
14. Frust DE, Koehnke R, Burmeister LF, Kohler J, Cargill J (1989) Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. Journal of Rheumatology, 16, 313 320.